Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 36 NSCLC 9 Meningeal Carcinomatosis 5 Adenocarcinoma of Lung 5 Lung Neoplasms 4 Brain Neoplasms 4 Respiratory Tract Neoplasms 1 Pleural Effusion, Malignant 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasm, Residual 1 Multiple Primary Lung Cancers 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer 1 EGF-R Positive Non-Small Cell Lung Cancer 1 Carcinoma 1 Bronchial Neoplasms 1 Advanced Non-small Cell Lung Cancer 1 Advanced NSCLC Patients With T790M 1 Advanced NSCLC 1 Advanced Lung Cancer 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Primary Lung Cancers × aflutinib × Clear all

NCT04982900 2021-10-05

TERMGGO

Ruijin Hospital

Phase 2 Unknown

Multiple Primary Lung Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡